(Q27650271)
Statements
The design and synthesis of diaryl ether second generation HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) with enhanced potency versus key clinical mutations (English)
0 references
1 May 2008
0 references
18
0 references
9
0 references
2959-66
0 references